To determine how ORM2 induces IL-6 and CXCL8 production, we treated RA-FLSs with recombinant human ORM2 in the presence of chemical inhibitors specific for NF-κB and p38 MAP kinase. The gene discussed is ORM2; the disease is rheumatoid arthritis.